Literature DB >> 32532491

Three simple metrics to define in vitro fertilization success rates.

Catha Fischer1, Richard T Scott2.   

Abstract

Describing clinical outcomes from assisted reproduction technology (ART) treatment cycles has been an evolving challenge throughout the world. Three simple metrics provide a transparent and highly accurate summary of ART outcomes. The first metric is the probability of having no embryos available to transfer. This metric incorporates all causes of failure from initiation of the treatment cycle up to the point immediately before actual embryo transfer. Patients will know what the risk is of failing, whether it is due to poor follicular stimulation, failed fertilization, poor embryo development, or abnormal preimplantation genetic testing for aneuploidy (PGT-A) results. The second and most important metric is sustained implantation rate: the probability that any transferred embryo will implant and progress to delivery. In the event of a single-embryo transfer, the metric is identical to delivery rate per transfer. By calculating per embryo, it provides a summary of the quality of outcomes within the program without the obscuring effect of multiple-embryo transfer. The final metric is the number of supernumerary embryos cryopreserved during the cycle. This speaks to the efficiency of the process by providing an estimate of potential benefits which may come from an additional transfer should the first one be unsuccessful or even to allow the couple to pursue an additional child without another full ART cycle. These metrics are easy to calculate and provide a detailed picture of the outcomes attained by the program.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  ART; IVF; clinical outcomes; metrics; success rates

Year:  2020        PMID: 32532491     DOI: 10.1016/j.fertnstert.2020.04.056

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Mosaic human preimplantation embryos and their developmental potential in a prospective, non-selection clinical trial.

Authors:  Antonio Capalbo; Maurizio Poli; Laura Rienzi; Laura Girardi; Cristina Patassini; Marco Fabiani; Danilo Cimadomo; Francesca Benini; Alessio Farcomeni; Juliana Cuzzi; Carmen Rubio; Elena Albani; Laura Sacchi; Alberto Vaiarelli; Matteo Figliuzzi; Necati Findikli; Onder Coban; Fazilet K Boynukalin; Ivan Vogel; Eva Hoffmann; Claudia Livi; Paolo E Levi-Setti; Filippo M Ubaldi; Carlos Simón
Journal:  Am J Hum Genet       Date:  2021-11-18       Impact factor: 11.025

2.  More blastocysts are produced from fewer oocytes in ICSI  compared to IVF - results from a sibling oocytes study and definition of a new key performance indicator.

Authors:  Sandrine Chamayou; Carmen Ragolia; Carmelita Alecci; Giorgia Storaci; Simona Romano; Roberta Sapienza; Elena Maglia; Annalisa Liprino; Clementina Cardea; Michele Fichera; Antonino Guglielmino
Journal:  Reprod Biol Endocrinol       Date:  2021-07-26       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.